Table 2.
Group | Total | Strong | Weak | P-value |
---|---|---|---|---|
Neoadjuvant regimen | ||||
FOLFIRI | 30 | 12 | 18 | 0.271 |
FOLFOX | 10 | 3 | 7 | |
Other | 10 | 2 | 8 | |
Mean number of courses, n | 8 | 8 | 8 | 0.875 |
Response rate by RECIST26 | 0.046 | |||
Complete response | 1 | 1 | 0 | |
Partial response | 23 | 11 | 12 | |
Stable disease | 19 | 5 | 14 | |
Progressive disease | 7 | 0 | 7 | |
Portal vein embolization, n | 5 | 2 | 3 | 0.765 |